Microtubule inhibitor-based antibody-drug conjugates for cancer therapy.

Klute, Kelsey; Nackos, Eleni; Tasaki, Shinsuke; Nguyen, Daniel P; Bander, Neil H; Tagawa, Scott T

Klute, Kelsey; Nackos, Eleni; Tasaki, Shinsuke; Nguyen, Daniel P; Bander, Neil H; Tagawa, Scott T.

Afiliação

Klute K; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Nackos E; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Tasaki S; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Nguyen DP; Department of Urology, Weill Cornell Medical College, New York, NY, USA.
Bander NH; Department of Urology, Weill Cornell Medical College, New York, NY, USA.
Tagawa ST; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA ; Department of Urology, Weill Cornell Medical College, New York, NY, USA.

Onco Targets Ther ; 7: 2227-36, 2014.

Article em En | MEDLINE | ID: mdl-25506226

Palavras-chave

antibodydrug conjugate; microtubule inhibitor; monoclonal antibody

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos